Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1999
06/02/1999CN1218408A Method of treatment
06/02/1999CN1218407A Stimulation of host defence mechanisms against tumors
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218405A Treatment of cystic disease with TNF-'alpha'
06/02/1999CN1218404A HLA binding peptides and their uses
06/02/1999CN1218394A Dispersible macromolecule compositions and methods for their preparation and use
06/02/1999CN1218057A New immunological activity for peptide of limulus anti-LPS factor
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908925 Genetically engineered immunoglobulins with specificity for glycated albumin
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908920 Cell cycle regulatory gene
06/01/1999US5908919 Drug delivery
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908835 Anti-tumor compositions containing taxane derivatives
06/01/1999US5908832 Peptide analog
06/01/1999US5908831 Polypeptides
06/01/1999US5908830 Combination therapy for the treatment of diabetes and obesity
06/01/1999US5908829 Use of MCP-1 for inducing ripening of the cervix
06/01/1999US5908828 Bone disorders
06/01/1999US5908827 Protein from urine named component B
06/01/1999US5908826 Freeze-dried preparation containing monoclonal antibody
06/01/1999US5908825 Dosage composition for nasal delivery and method of use of the same
06/01/1999US5908824 Dispersed homogeneously in and adsorbed homogeneously onto a mucosa protecting and/or tissue repairing agent
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908763 Granulocyte-macrophage colony stimulating factor; for myelo-suppression caused by cancer treatments of irradiation and chemotherapy
06/01/1999US5908762 Chimeric dna molecule coding for cysteine-rich polypeptide which suppresses transcription of major histocompatibility complex class ii molecules; autoimmune diseases
06/01/1999US5908747 Isolated wildtype gene in nuclear chromosomes coding a polypeptide that induces homologous recombination in mitochondria; aging resistance agent
06/01/1999US5908697 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
06/01/1999US5908633 Poly-para-xylylene matrix
06/01/1999US5908627 Antigen associated with Type I diabetes mellitus
06/01/1999US5908626 Genetic engineering
06/01/1999US5908625 Administering a genetic engineered protein
06/01/1999US5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
06/01/1999US5908621 Polyethylene glycol modified interferon therapy
06/01/1999US5908620 Treatment for diseases involving inflammation
06/01/1999US5908609 Screening methods for compounds useful in the regulation of body weight
06/01/1999CA2141372C Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient, maximizing its release and its use
05/1999
05/28/1999CA2223225A1 Method for inhibiting in vivo immune response
05/28/1999CA2219271A1 1-deoxy-d-xylulose 5-phosphate synthase, a process for identifying effectors of 1-deoxy-d-xylulose 5-phosphate synthase and effectors of 1-deoxy-d-xylulose 5-phosphate synthase
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025850A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025849A1 Single-chain bifunctional glycoprotein hormones
05/27/1999WO1999025844A1 Mammalian cell death preventing kinase, dpk
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025836A1 Attaching substances to micro-organisms
05/27/1999WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999WO1999025833A1 Methods for modulating nerve cell function
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025831A2 Slit polypeptide and method of modulation of robo with ligands
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025826A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999WO1999025823A2 Recombinant allergen with reduced enzymatic activity
05/27/1999WO1999025822A1 The exostosin-4 gene
05/27/1999WO1999025819A2 Antisense oligonucleotides against tenascin for treating vitiligo
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025813A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells
05/27/1999WO1999025812A1 Method for the production and use of dendritic cells
05/27/1999WO1999025737A1 Compositions and methods for treatment of autoimmune diseases, using a monoclonal antibody to the interleukin-12 beta2-chain
05/27/1999WO1999025736A1 Chronic lymphocytic leukemia nucleotides and proteins
05/27/1999WO1999025733A2 SUBSTANCES TARGETED TO THE ACTIVE SITE OF THE FtsH PROTEIN, DNA ENCODING SAID SUBSTANCES AND USES THEREOF
05/27/1999WO1999025732A2 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors
05/27/1999WO1999025731A1 Cyclic peptides and medicinal use thereof
05/27/1999WO1999025730A1 Ikap proteins, nucleic acids and methods
05/27/1999WO1999025729A1 Compounds with antitumor activity
05/27/1999WO1999025728A1 Novel exendin agonist compounds
05/27/1999WO1999025727A2 Novel exendin agonist compounds
05/27/1999WO1999025721A1 Detection and treatment of retinal degenerative disease
05/27/1999WO1999025719A1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof
05/27/1999WO1999025690A2 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999WO1999025387A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
05/27/1999WO1999025383A1 Conjugates comprising two active agents
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025375A2 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
05/27/1999WO1999025374A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/27/1999WO1999025373A1 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025371A1 Novel molecules of the follistatin-related protein family and uses therefor
05/27/1999WO1999025366A1 Use of cytokines and mitogens to inhibit pathological immune responses
05/27/1999WO1999025352A1 Combination therapy for the treatment of aids
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999025324A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein
05/27/1999WO1999014357A3 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999012563A3 Mucosal cytotoxic t lymphocyte responses
05/27/1999WO1999011780A3 Conductine protein and a related agent for diagnosing and treating tumor illnesses
05/27/1999WO1999011655B1 Modular protein libraries and methods of preparation
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999WO1999010004A3 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
05/27/1999WO1999006554A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
1 ... 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 ... 3163